Fragment Screening and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Fragment Screening

Pharmaceuticals

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands. For fragment screening, which are much smaller compounds, we have a library of about 3000 fragments. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Biophysics

Sygnature Discovery

JUNE 17, 2024

Biophysics in Drug Discovery: A Sygnature Approach Our key biophysics leaders alone possess over 50 years of combined experience in drug discovery, spanning CRO, pharmaceutical, and biotech sectors, and applied across various target classes and therapeutic modalities. Nucleic Acid Targets: Focusing on specific interactions and functions.

Biophysical Assays

Biophysical Assays Screening Hits Assay Development Fragment Screening

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Biophysics

Stay Connected